UnitedHealth Group's CEO Andrew Witty steps down amid higher medical costs leading to suspension of 2025 financial forecast, with Stephen Hemsley returning as CEO.

UnitedHealth Group appoints Stephen J. Hemsley as CEO and suspends its 2025 financial outlook due to rising Medicare Advantage medical costs, with growth expected to resume in 2026.

CMS issued final rules and updates for Medicare Advantage and Part D programs for 2026, including Inflation Reduction Act implementations and inpatient care protections.

Democrats call on GOP leaders to stop Medicaid cuts and focus on Medicare Advantage upcoding to reduce $50 billion in federal overpayments and protect healthcare coverage.

UnitedHealth Group faces a securities class action lawsuit after slashing 2025 earnings guidance and reporting Q1 losses, raising issues on Medicare Advantage utilization and corporate disclosures.

UnitedHealth Group cuts profit forecasts due to higher Medicare Advantage care costs and lower coding revenue, highlighting challenges in Medicare Advantage management and insurance financials.

The DOJ sued SelectQuote and major insurers over Medicare Advantage plan kickbacks, leading to a 19% stock drop. This case highlights key compliance risks in broker compensation and Medicare Advantage enrollment.

Levi & Korsinsky LLP has commenced an investigation into CVS Health following DOJ allegations of illegal kickbacks related to Medicare Advantage plan enrollments, highlighting increased regulatory focus on insurance brokerage compliance.

AM Best affirms stable A (Excellent) financial strength and credit ratings for Aetna Health & Life Group and CVS Health subsidiaries, highlighting strong capital adequacy and improved underwriting outlooks for 2025.

In 2025, major U.S. health insurers face financial and operational setbacks while smaller, focused payers achieve significant growth by leveraging market-specific strategies and managing costs effectively, reshaping the Medicare Advantage and ACA markets.